Abstract
Sir2, an NAD+-dependent protein deacetylase, extends the lifespan in diverse species from yeast to flies. Mammals have seven homologs of Sir2, SIRT1-7, which affect aging and metabolism and which are potential targets for pharmacologic intervention. We identified SIRT2, which preferentially deacetylates tubulin and histone H4, as a downregulated protein in gliomas due to its epigenetic aberration. We herein discuss the role of SIRT2 in the mitotic checkpoint function and show that it may be as a potential target of anti-cancer drugs.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Aneuploidy
-
Animals
-
Cell Cycle / physiology*
-
Histone Deacetylases / genetics
-
Histone Deacetylases / metabolism
-
Histones / metabolism
-
Humans
-
Mice
-
Mitosis
-
Models, Biological
-
Neoplasms / drug therapy
-
Neoplasms / metabolism
-
Polyploidy
-
Silent Information Regulator Proteins, Saccharomyces cerevisiae / genetics
-
Silent Information Regulator Proteins, Saccharomyces cerevisiae / metabolism
-
Sirtuin 2
-
Sirtuins / genetics
-
Sirtuins / metabolism
-
Sirtuins / physiology*
-
Tubulin / metabolism
Substances
-
Histones
-
Silent Information Regulator Proteins, Saccharomyces cerevisiae
-
Tubulin
-
SIR2 protein, S cerevisiae
-
Sirtuin 2
-
Sirtuins
-
Histone Deacetylases